Join the Nasonex group to help and get support from people like you.
Nasonex News
FDA Approves Nasonex 24HR Allergy (mometasone furoate) Nasal Spray for OTC Use
DUBLIN, March 17, 2022 /PRNewswire/ – Perrigo Company plc (NYSE: PRGO), a leading provider of Quality, Affordable Self-Care Products, today announced that it has received final approval from the...
Further information
Related condition support groups
Nasal Polyps, Hay Fever, Allergic Rhinitis